Prescribing of dabigatran etexilate in accordance with the European label for stroke prevention in atrial fibrillation: Findings from the GLORIA-AF Registry
第一作者机构:[1]Univ Birmingham, Ctr Cardiovasc Sci, Birmingham, W Midlands, England;
推荐引用方式(GB/T 7714):
Lip G. Y. H.,Teusch C.,Huisman M. V.,et al.Prescribing of dabigatran etexilate in accordance with the European label for stroke prevention in atrial fibrillation: Findings from the GLORIA-AF Registry[J].EUROPEAN HEART JOURNAL.2017,38:975-975.
APA:
Lip, G. Y. H.,Teusch, C.,Huisman, M. V.,Diener, H. C.,Dubner, S. J....&Halperin, J. L..(2017).Prescribing of dabigatran etexilate in accordance with the European label for stroke prevention in atrial fibrillation: Findings from the GLORIA-AF Registry.EUROPEAN HEART JOURNAL,38,
MLA:
Lip, G. Y. H.,et al."Prescribing of dabigatran etexilate in accordance with the European label for stroke prevention in atrial fibrillation: Findings from the GLORIA-AF Registry".EUROPEAN HEART JOURNAL 38.(2017):975-975